Friday 28 June 2019

Cell Therapy Market Size, Share, Trends, Growth, Report Value | Industry Report

The global cell therapy technologies market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4% during the forecast period.
 Factors such as rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are driving the growth of this market.

China, India, Japan, Korea, and Brazil are emerging markets for cell therapy instruments. These markets boast comparatively lenient standards and government regulations as opposed to developed markets in North America and the EU, and thus offer significant growth potential for providers. However, the high cost of cell-based research and the low success rate is expected to restrain market growth to some extent during the forecast period.


The global cell therapy technologies market segmentation:
§  cell processing
§  cell preservation
§  distribution And handling
§  cell process monitoring and quality control

Key Market Players

Key players in this cell therapy technologies market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).

Thermo Fisher was the largest player in the cell therapy technologies market in 2017. In order to maintain its position in the market and further expand its product portfolio, the company focuses on the strategies of product launches, acquisitions, and expansions. Merck holds the second position in the cell therapy technologies market. The company focuses on collaborations, agreements, and acquisitions to enhance its market position.

Geographical Detailed Analysis for the cell therapy instruments market :

The market, by region, is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of this market in 2018. The large share of this regional segment can primarily be attributed to the high burden of chronic diseases and increasing R&D activities in pharmaceutical and biotechnology industries.

The market is dominated by players such as Beckman Coulter, Inc. (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (US), and Thermo Fisher Scientific, Inc. (US).

Read More in Detailed (cell therapy instruments market): 

https://www.marketsandmarkets.com/PressReleases/cell-therapy-technologies.asp

Thursday 27 June 2019

Bioinformatics Market worth $23.89 billion in 2027, at CAGR of 14.5%


The global bioinformatics market is projected to reach $23.89 billion in 2027 from $8.09 billion in 2018, at CAGR of 14.5%.

Growing demand for nucleic acid and protein sequencing, initiatives from government and private organizations, growing applications of bioinformatics, and the increasing number of collaborations between companies and research institutes are the major factors driving the growth of the market.


Global bioinformatics market segmentation:
·         Based on product and service
·         Based on applications
·         Based on sector

The Major Players Opearting in the Bioinformatics Market Key Players

Key players that provide bioinformatics products and services are Thermo Fisher Scientific (US), Illumina Inc (US), Agilent Technologies (US), QIAGEN (Netherlands), BGI (China), Wuxi NextCODE (China), Eurofins Scientific (Luxembourg), Waters Corporation (US), Sophia Genetics (Switzerland), Partek (US) and DNASTAR (US). These players focus on both organic and inorganic growth strategies such as product launches, partnerships, and agreements to maintain and enhance their market share in the market.

One of the major factors restraining market growth is the lack of well-defined standards and common formats for data integration. Most of the research institutes have their own exclusive identifiers, indexing schemes, and data formats. As data models change frequently, the data integration process becomes difficult. This may limit the growth of the market to a certain extent.

Geographical Detailed Analysis for Bioinformatics Market :

North America is expected to account for the largest share of the market. The large share of North America is attributed to the continued funding from the government and private sectors for life sciences research.

 One of the major factors restraining market growth is the lack of well-defined standards and common formats for data integration. Most of the research institutes have their own exclusive identifiers, indexing schemes, and data formats. As data models change frequently, the data integration process becomes difficult. This may limit the growth of the market to a certain extent.

Read More in Detailed (Bioinformatics Market):


Tuesday 25 June 2019

Infectious Disease Diagnostics Market worth $25.43 billion by 2027

The report "Infectious Disease Diagnostics Market by Product & Service(Assay, Kit & Reagent, Instruments), Disease Type(Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology(Immunodiagnostics, PCR, NGS), End User(Hospital, Research Institute) - Global Forecast to 2027", The global infectious disease diagnostics market is expected to reach USD 25.43 billion by 2027 from USD 15.57 billion in 2018, at a CAGR of 5.6%. The increasing global prevalence of infectious diseases, the shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics are some the factors driving the growth of this market.

Browse 85 market data Tables and 35 Figures spread through 170 Pages and in-depth TOC on "Infectious Disease Diagnostics Market by Product & Service(Assay, Kit & Reagent, Instruments), Disease Type(Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology(Immunodiagnostics, PCR, NGS), End User(Hospital, Research Institute) - Global Forecast to 2027"https://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html
North America dominated the market in 2018
In 2018, North America accounted for the largest share of the global infectious disease diagnostics market. This largest share is attributed to the presence of a highly developed healthcare system, increasing prevalence of infectious diseases, the presence of a large number of leading national clinical laboratories, and easy accessibility to technologically advanced instruments in the region.
The key players in the global infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), bioMérieux (France), Bio-Rad (US), and Roche (Switzerland).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Bioinformatics Market worth $23.89 billion in 2027

The report Bioinformatics Market by Product & Service (Knowledge Mangement Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) — Global Forecast to 2027”, The global bioinformatics market is projected to reach USD 23.89 billion in 2027 from USD 8.09 billion in 2018, at CAGR of 14.5%. Growing demand for nucleic acid and protein sequencing, initiatives from government and private organizations, growing applications of bioinformatics, and the increasing number of collaborations between companies and research institutes are the major factors driving the growth of the market.

Browse 189 market data Tables and 27 Figures spread through 195 Pages and in-depth TOC on “Bioinformatics Market by Product & Service (Knowledge Mangement Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) — Global Forecast to 2027”
https://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html
Market Players
The bioinformatics market is highly competitive due to the presence of a large number of players. Few of the major companies in bioinformatics market are Thermo Fisher Scientific (US), Illumina Inc (US), Agilent Technologies (US), QIAGEN (Netherlands), BGI (China), Wuxi NextCODE (China), Eurofins Scientific (Luxembourg), Waters Corporation (US), Sophia Genetics (Switzerland), Partek (US), and DNASTAR (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Tuesday 18 June 2019

Women’s Health Diagnostics Market Size, Share, Forecast | Industry Forecast

According to the new market research report" Women’s Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021", published by MarketsandMarkets™,The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period.
Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market.

Get Sample Copy for more Professional and Technical insights @ https://www.marketsandmarkets.com/ResearchInsight/womens-health-diagnostics-market.asp

In this report, the global women health diagnostics market is segmented on the basis of application and end user. On the basis of application, the market is segmented into nine segments namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound. The osteoporosis segment is further divided into bone densitometry and in vitro blood tests. The ovarian cancer segment is divided into tumor marker tests, diagnostic imaging tests and others. The cervical cancer segment is sub segmented into PAP smear testing and HPV testing.

Browse and in-depth TOC on "Women’s Health Diagnostics Market"
265  - Tables
37  - Figures
292  - Pages

Browse 265 market data tables and 37 figures spread through 292 pages and in-depth TOC on “Womens Health Diagnostics Market by application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021”


The global women health diagnostics market is segmented on the basis of application, end user, and region. On the basis of application, the market is segmented nine segments, namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound. On the basis of end users, the women health diagnostics market is segmented into hospital & clinics, home healthcare, and diagnostic & imaging centers.

Geographically, the global market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded the largest share of the global women health diagnostics market. The major share of this region can be attributed to increasing prevalence of cancer among women in this region, increasing incidence of lifestyle related health disorders, growing focus of manufacturers of women’s health diagnostic products on expanding their presence in this region, and increasing demand for fertility testing monitors.

Make an Inquiry Prior To Purchase this research study @https://www.marketsandmarkets.com/PressReleases/womens-health-diagnostics.asp

Monday 17 June 2019

Aesthetic/Cosmetic Lasers Market Trends & Resources | Industry Report


According to the new market research report" Aesthetic/Cosmetic Lasers Market by Type (Standalone (CO2, Er:YAG, Diode, Nd:YAG, Alexandrite, Pulsed-Dye), Multiplatform), Application (Acne, Scars, Tattoo Removal, Varicose Veins), End User (Hospitals, Medical Spa, Private clinics) - Forecasts to 2021", published by MarketsandMarkets™, The global aesthetic/cosmetic lasers market is estimated to grow at a CAGR of 10.2% during the forecast period, to reach USD 1,132.7 Million by 2021.

Growing adoption of noninvasive procedures, changing lifestyles, rising incidence of skin damage, reduction in procedural costs, and rise in medical tourism devices are the major factors driving the growth of the aesthetic/cosmetic lasers market. However, the rising adoption of energy-based devices and low focus of market players on aesthetic/cosmetic devices are restraining the growth of this market.


Get Sample Copy for more Professional and Technical insights @ https://www.marketsandmarkets.com/ResearchInsight/aesthetic-cosmetic-laser-market.asp
Research Methodology

This study estimates the aesthetic/cosmetic lasers market size for 2016 and projects its demand till 2021. Primary and secondary research was used to for market estimation and forecast. Various secondary sources such as directories, industry journals, and databases have been used to identify and collect information useful for this extensive commercial study of the aesthetic/cosmetic lasers market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the aesthetic/cosmetic lasers market

Browse and in-depth TOC on "Aesthetic/Cosmetic Lasers Market"

88 - Tables
43 - Figures
147 - Pages

In this report, the global aesthetic/cosmetic lasers market is segmented on the basis of type, application, end user, and region.
Based on type, the aesthetic/cosmetic lasers type market is segmented into standalone lasers and multiplatform lasers. In this market, multiplatform lasers formed the fastest-growing segment as they provide scalable and upgradeable hybrid systems that can treat multiple indications. Factors such as multiplatform lasers provide clinicians the flexibility and versatility of several standalone systems in a single package, and provide combination therapy to synergistically treat a single indication or provide treatment addressing multiple elements of any indication is contributing to the high growth of this segment in the forecast period.

Order a copy of “Aesthetic/Cosmetic Lasers Market” research study @https://www.marketsandmarkets.com/PressReleases/aesthetic-cosmetic-laser.asp

Major players in the aesthetic/cosmetic lasers market include Aerolase (U.S.), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), El.En. SpA (Italy), Lumenis Ltd. (Israel), Sciton, Inc. (U.S.), SharpLight Technologies (Israel), Syneron Medical Inc. (Israel), and Solta Medical (U.S.).
The global aesthetic/cosmetic lasers market is dominated by Cynosure (U.S.), Syneron Medical (Israel), Lumenis Ltd. (Israel), and Cutera, Inc. (U.S.), owing to their global presence and broad product portfolio in the global aesthetic/cosmetic lasers market.


Thursday 13 June 2019

Digital Therapeutics Market Industry Analysis, Size, Share, Growth, Trends and Forecast


According to the new market research report " Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.

Get Sample Copy for more Professional and Technical insights at : https://www.marketsandmarkets.com/ResearchInsight/digital-therapeutics-market.asp


The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics. However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.

Browse and in-depth TOC on "Digital Therapeutics Market"
148  - Tables
36  - Figures

 Order a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at:
The digital therapeutics market is highly fragmented, diversified, and increasingly competitive, with a large number of small players competing for market space, including startup firms. Each segment has different market players and market leaders. For instance, the prediabetes market was led by Omada in 2015. Omada Health is a leading provider of digital therapeutics for preventable type 2 diabetes and heart disease. Omada’s product portfolio consists of ‘Prevent’, an online diabetes prevention program. The company has succeeded in securing heavy investments which it channelizes into the development, enhancement, and commercialization of its product. 


Wednesday 12 June 2019

Healthcare Information Exchange Market| Statistics & Trends | MarketsandMarkets™


According to the new market research report "Health Information Exchange Market by Set Up Type (Public, Private), Type (Pull, Push), Implementation Model (Federated, Hybrid), Application (Web Portal, Secure Messaging), Solution Type (Portal, Platform Centric), & End Users - Global Forecast to 2020", published by MarketsandMarkets™, The health information exchange market is projected to reach USD 1,545.0 million by 2020 from USD 990.6 million in 2015, at a CAGR of 9.3% during the forecast period.

Don’t miss out on business opportunities in Health Information Exchange Market


Federal mandates like Meaningful use, growing patient-centric approach in healthcare delivery, increasing EHR adoption rate, and need to curtail healthcare cost are some of the key factors driving the growth of market.
Health information exchange (HIE) involves the electronic movement of health-related information among organizations according to nationally recognized standards. HIE aims to facilitate the access and retrieval of clinical data to provide safer, timelier, efficient, effective, equitable, patient -centered care. HIE enables collaboration between healthcare stakeholders, cuts down on administrative tasks, and eventually provides greater transparency in the field of healthcare. HIE is an ever-changing concept. Continuously changing technological and regulatory environment consistently evolves the HIE space.


Browse and in-depth TOC on "Health Information Exchange Market"

78  - Tables
41 - Figures
201 - Pages

This increasing usage of electronic health record as well as web portals for easy retrieval of patient information is driving the market for web portal development application segment

Web portal development

Over the years, web portals have been used in healthcare organizations to schedule appointments, register patients, and send secure email to providers. They are also used to provide laboratory results, refill prescription requests, and maintain personal health records. According to Stage 2 of Meaningful Use, patients should have access to view and download electronic copies of their own medical records. Web portals help in retrieving patient information, in an easier and efficient manner as compared to obta ining health records manually.

Workflow management

HIEs and EHRs help healthcare professionals in health management and enable better decision-making for enhanced patient care. HIEs also facilitate reduction in duplicative treatment, thus avoiding additional expenses.

Make an Inquiry Prior To Purchase this research study at: https://www.marketsandmarkets.com/PressReleases/healthcare-information-exchange.asp

Tuesday 11 June 2019

Vaccine Adjuvants Market | Growth, Size, Trends, and Forecast Vaccine Adjuvants Market


According to the new market research report " Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021 ", published by MarketsandMarkets™, The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%. The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

Don’t miss out on business opportunities in Vaccine Adjuvants Market


Browse and in-depth TOC on "Vaccine Adjuvants Market"
90 - Tables
42 - Figures
156 - Pages

Geographically, the vaccine adjuvants market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is projected to grow at the highest CAGR during the forecast period. Growth in the North American segment is primarily driven by the increasing geriatric population and rising incidences of diseases in the North American countries.
The major players in the vaccine adjuvants market are Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).

Read More Report @ https://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html

Value Addition for the Buyer:
This report aims to provide insights into the global vaccine adjuvants market. It provides valuable information on the product type, route of administration, disease type, applications, and application categories in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

To read research insights, visit: https://www.marketsandmarkets.com/ResearchInsight/vaccine-adjuvants-market.asp

Monday 10 June 2019

Varicose Veins Treatment Market Size | Industry Report| MarketsandMarkets™


According to the new market research report "Varicose Vein Treatment Market by Products (Laser & RF Ablation, Venous Closure, Surgical), Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Region (North America, Europe) - Forecasts to 2021", published by MarketsandMarkets™,The varicose vein treatment market is projected to reach to reach $289.7 million by 2021 from $207.9 million in 2016, growing at a CAGR of 6.9% from 2016 to 2021.

Don’t miss out on business opportunities in Varicose Veins Treatment Market


Browse and in-depth TOC on "Varicose Vein Treatment Market"
67 - Tables
19 - Figures
149 - Pages


Research Methodology
This research study involved the extensive use of secondary sources, directories, and databases (such as Hoovers, Bloomberg Business, Factiva, and Avention) to identify and collect information useful for this technology-based, market-oriented, and commercial study of the North America and Europe varicose vein treatment market. In-depth interviews were conducted with various primary respondents that mainly included key industry participants, subject-matter experts (SMEs), C & D level executives of key market players, and independent industry consultants, among others; to obtain and verify critical qualitative and quantitative information as well as to assess future market prospects of the varicose vein treatment industry.

To know about the assumptions considered for the study, download the pdf brochure
Objectives of the study are:
·         To define, describe, and forecast the market in North America and Europe on the basis of mode of treatment, products, and regions
·         To provide detailed information regarding major factors influencing the growth of the market in North America and Europe (drivers, restraints, opportunities, and industry-specific challenges)
·         To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
·         To strategically profile the key players and comprehensively analyze their market shares


The global market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021. Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the market. Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Friday 7 June 2019

Transplant Diagnostics Market Size, Industry Analysis, Share, Growth | MarketsandMarkets™


According to the new market research report " HLA Typing for Transplant Market by Technology (SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing), Products & Services (Instruments, Reagents, Software), Application (Diagnostics, Research), End User (Hospitals, Academia, Diagnostic Center) - Forecast to 2021", published by MarketsandMarkets™,The global HLA typing for transplant market is projected to reach USD 753.9 Million by 2021 from USD 535.0 Million in 2016, at a CAGR of 7.1% from 2016 to 2021.


Don’t miss out on business opportunities in Transplant Diagnostics Market

Browse and in-depth TOC on "Transplant Diagnostics Market"
60  - Figures
203 - Pages

 Market growth can be attributed to factors such as the rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements in the field of organ transplantation; increased funding, research grants, and public-private investments; technological shift from serological assays to gene-based HLA profiling; and improving healthcare infrastructure across developing countries.
To know about the assumptions considered for the study, download the pdf brochure
Scope of the Report
This research report categorizes the HLA typing for transplant market into the following segments and sub segments:
HLA Typing for Transplant Market, By Technology
·         Non-Molecular Assay
§  Serological Assay
§  Mixed Lymphocyte Culture Assay (MLC Assay)
·         Molecular Assay
§  PCR-based
o   Sequence specific primer-PCR (SSP-PCR)
o   Sequence specific oligonucleotide-PCR (SSO-PCR)
·         Sequencing-based
§  Next Generation Sequencing
§  Sanger’s Sequencing

Please click here to get the global report of Transplant Diagnostics Market by Technology (PCR, SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing, Microarray), Products & Services (Instruments, Reagents), Application (Blood Profiling, Infectious Disease Testing), End User (Hospitals) - Global forecast 2021

The global HLA typing for transplant market is projected to reach USD 753.9 Million by 2021 from USD 535.0 Million in 2016, growing at a CAGR of 7.1% from 2016 to 2021. Market growth can be attributed to factors such as the rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements in the field of organ transplantations; and increased funding, research grants, and public-private investments. However, the high device costs associated with NGS and PCR-based devices and limited medical reimbursements for organ donation and transplantation procedures restrain the optimal growth of the HLA typing for transplant market. 

To speak to our analyst for a discussion on the above findings, click Speak to Analyst